3D Bioprinting BioBots Wants Piece of $50 Billion Pharmaceutical Industry Research Spend

3D bioprinting technology startup, BioBots, is seeking to disrupt the nascent field of bioprinting with its new printer for 3D living tissue creation. At only USD$5,000 per printer, I would say they are off to a pretty good start.

3D bioprinting is not new: It began in the mid-1990s. Recently, many bioprinting efforts talk about the technology as a way to speed up the government requirements for getting a new drug to market.
(...weiter auf forbes.com)